Graf Akcie APLS (Apellis Pharmaceuticals Inc). Diskuze k akciím APLS. Aktuální informace APLS.

Základní informace o společnosti Apellis Pharmaceuticals Inc (Akcie APLS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.85B
Hodnota podniku (EV) N/A
Tržby 251.269M
EBITDA N/A
Zisk -460.29
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.54
EV/Sales 10.40
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 11.35
P/FCF N/A
Price/Book 13.94
Účetní hodnota na akcii 2.51
Hotovost na akcii 10.76
FCF vůči ceně -8.59 %
Počet zaměstnanců 374
Tržba na zaměstnance 671.842k
Profit margin -137.59 %
Operating margin -126.07 %
Gross margin 100.00 %
EBIT margin -171.68 %
EBITDA margin -44,492.23 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 73.25 %
EPS - Očekávaný růst příští rok -7.82 %
Return on assets -56.84 %
Return on equity -834.75 %
ROIC -46.39 %
ROCE -79.57 %
Dluhy/Equity 3.70
Čistý dluh/EBITDA 5.26
Current ratio 4.15
Quick Ratio 4.13
Volatilita 6.16
Beta 1.17
RSI 40.33
Cílová cena analytiků 53
Známka akcie (dle analytiků) 1.43
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 87.003M
Procento shortovaných akcií 8.38 %
Short ratio 6.09 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1970
Země United States

Finanční výsledky akcie APLS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue-----
Cost Of Goods Sold-----
Gross Profit-----
Research And Development Expenses$220.969$105.286$40.304$22.979$13.73
SG&A Expenses$67.047$22.639$10.463$4.304$6.357
Other Operating Income Or Expenses-----
Operating Expenses$288.015$127.925$50.767$27.282$46.573
Operating Income$-288.015$-127.925$-50.767$-27.282$-46.573
Total Non-Operating Income/Expense$-16.691$0.423$-0.239$0.158$0.057
Pre-Tax Income$-304.707$-127.502$-51.006$-27.125$-46.516
Income Taxes-----
Income After Taxes$-304.707$-127.502$-51.006$-27.125$-46.516
Other Income-----
Income From Continuous Operations$-304.707$-127.502$-51.006$-27.125$-46.516
Income From Discontinued Operations-----
Net Income$-304.707$-127.502$-51.006$-27.125$-46.516
EBITDA$-285.434$-127.343$-50.755$-27.282$-46.573
EBIT$-288.015$-127.925$-50.767$-27.282$-46.573
Basic Shares Outstanding62541486
Shares Outstanding62541486
Basic EPS$-4.90$-2.34$-3.68$-3.22$-8.03
EPS - Earnings Per Share$-4.90$-2.34$-3.68$-3.22$-8.03
# 2020 2019 2018 2017 2016 2015
Current Ratio5.674211.89127.77187.521111.8881
Long-term Debt / Capital0.80640.13620.1505--
Debt/Equity Ratio4.1650.1680.1772--
Gross Margin-----
Operating Margin-----
EBIT Margin-----
EBITDA Margin-----
Pre-Tax Profit Margin-----
Net Profit Margin-----
Asset Turnover-----
Inventory Turnover Ratio-----
Receiveable Turnover-----
Days Sales In Receivables-----
ROE - Return On Equity-890.1816-79.2074-34.245439.7369110.1883
Return On Tangible Equity-890.1818-79.2074-34.2454-113.9963-132.9903
ROA - Return On Assets-78.2814-62.6443-28.0051-98.875-121.8425
ROI - Return On Investment-172.3488-68.4208-29.091-113.9963-132.9903
Book Value Per Share0.53542.86032.95912.82324.1501
Operating Cash Flow Per Share-0.98020.9465-0.27390.1685-3.2538
Free Cash Flow Per Share-1.00740.9465-0.27390.1685-3.2538

Porovnání s konkurencí: Akcie APLS

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
APLS 0.00 N/A N/A % -7.82 % -834.75 % 13.94 -137.59 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 10.05 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 10.05 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 10.05 -894.31 %

Nedávné obchody insiderů: Akcie APLS

Jméno Obchod Cena Objem
Pascal Deschatelets
Chief Scientific Officer
Option
10 Mar 2021
$2.67 $16,688
Federico Grossi
CHIEF MEDICAL OFFICER
Option
5 Mar 2021
$3.20 $16,000
Federico Grossi
CHIEF MEDICAL OFFICER
Prodej
1 Mar 2021
$48.58 $29,148
Nicole D Perry
Vice President - Accounting
Option
1 Mar 2021
$3.76 $7,520
Nicole D Perry
Vice President - Accounting
Option
4 Jan 2021
$3.76 $7,520
Federico Grossi
CHIEF MEDICAL OFFICER
Prodej
4 Jan 2021
$57.24 $34,344
Federico Grossi
CHIEF MEDICAL OFFICER
Prodej
14 Jan 2021
$51.99 $207,960
Alec Machiels
Director
Option
15 Jan 2021
$2.67 $6,675
Federico Grossi
CHIEF MEDICAL OFFICER
Option
25 Jan 2021
$3.63 $54,450
David O. Watson
General Counsel
Option
27 Jan 2021
$4.01 $174,367
Cedric Francois
Chief Executive Officer
Option
27 Jan 2021
$4.01 $287,826
Federico Grossi
CHIEF MEDICAL OFFICER
Prodej
1 Feb 2021
$44.00 $26,400
Nicole D Perry
Vice President - Accounting
Option
9 Feb 2021
$3.76 $7,520
Alec Machiels
Director
Option
16 Feb 2021
$2.67 $6,675
Federico Grossi
CHIEF MEDICAL OFFICER
Prodej
16 Feb 2021
$46.00 $23,000

Diskuze k akciím APLS